CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Returned to the company Director returned 420,000 shares (to the company)
- 4 Open-market buy 10% owner bought 300,000 shares at $5.76 ($1,727,370)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Director bought 700,761 shares at $6.75 ($4,730,137)
- 4 Open-market buy Director bought 700,761 shares at $6.75 ($4,730,137)
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 14,000 shares (option exercise)
- 4 Open-market sale Director sold 16,393 shares at an average $9.03 ($147,956)
Page 3 of 13 · 244 filings